D-amino acids are being recognized as functionally important molecules in mammals. We recently identified endogenous D-cysteine in mammalian brain. D-cysteine is present in neonatal brain in substantial amounts (mM) and decreases with postnatal development. D-cysteine binds to MARCKS and a host of proteins implicated in cell division and neurodevelopmental disorders. D-cysteine decreases phosphorylation of MARCKS in neural progenitor cells (NPCs) affecting its translocation. D-cysteine controls NPC proliferation by inhibiting AKT signaling. Exogenous D-cysteine inhibits AKT phosphorylation at Thr 308 and Ser 473 in NPCs. D-cysteine treatment of NPCs led to 50% reduction in phosphorylation of Foxo1 at Ser 256 and Foxo3a at Ser 253. We hypothesize that in the developing brain endogenous D-cysteine is as a physiologic regulator of NPC proliferation by inhibiting AKT signaling mediated by Foxo1 and Foxo3a. Endogenous D-cysteine may regulate mammalian neurodevelopment with roles in schizophrenia and Alzheimer's disease (AD). K E Y W O R D S chirality, D-amino acids, endogenous D-cysteine, MARCKS (myristoylated alanine-rich C kinase substrate), neural progenitor cells (NPC), racemization, serine racemase ABBREVIATIONS: CRAPome, (contaminant repository for affinity purification); IP-MS, (immunoprecipitation followed by mass spectrometry); MARCKS, (myristoylated alanine-rich C kinase substrate); MARCKSL1, (MARCKS Like 1); NPC, (neural progenitor cells); PKC, (protein kinase C); PSD, (phosphorylation site domain); SR, (Serine Racemase).